New sedative studied for Kids' surgery comfort
NCT ID NCT07036419
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called remimazolam to see how well it works and how safe it is for sedating children and teenagers during surgery. About 249 young patients took part. The goal was to see if the drug could successfully start and maintain sedation while keeping side effects low.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2/3
Runs two stages together: whether the treatment works, then large-scale confirmation.
- Participants
-
249 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
May 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
3 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Able and willing to provide a written informed consent. 2. Subjects requiring elective general anesthesia surgery. 3. Male or female. 4. Meet the weight standard. Exclusion Criteria: 1. Pediatric patients scheduled for elective cardiothoracic, neurosurgical, or hepatic surgery. 2. Patients who are planned to receive any anesthetic techniques other than total intravenous anesthesia (TIVA) from entry into the operating room until the end of surgery, such as inhalational anesthesia, epidural anesthesia, or spinal anesthesia. 3. Patients with a medical history or clinical evidence that may increase the risk of sedation or anesthesia and are deemed unsuitable for participation by the investigator. 4. Patients with a history of asthma or with risk for difficult mask ventilation or difficult intubation by the investigator's judgment. 5. With clinically significant abnormal clinical laboratory test value. 6. Known intolerance or allergy to benzodiazepines, propofol, opioids, neuromuscular blocking agents, or any of their components.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Operative sedation of adolescent patients are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200433, China